kynostatin 272 has been researched along with zidovudine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaji, K; Hamawaki, T; Kimura, T; Kiso, Y; Matsuda, T; Matsumoto, H | 1 |
| Bader, JP; Cragg, GM; Newman, DJ; Yang, SS | 1 |
| Erickson, J; Ford, H; Gulnik, S; Hayashi, H; Kageyama, S; Mimoto, T; Murakawa, Y; Nomizu, M; Shirasaka, T; Takada, K | 1 |
| Chokekijchai, S; Mitsuya, H; Shirasaka, T; Weinstein, JN | 1 |
| Kavlick, MF; Kosalaraksa, P; Mitsuya, H; Yusa, K | 1 |
| Aquaro, S; Caliò, R; Davis, DA; Humphrey, RW; Newcomb, FM; Perno, CF; Yarchoan, R | 1 |
| Gold, D; Loftus, R | 1 |
1 review(s) available for kynostatin 272 and zidovudine
| Article | Year |
|---|---|
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
Topics: Amino Acid Sequence; Anti-HIV Agents; HIV-1; Models, Biological; Models, Chemical; Molecular Sequence Data; National Institutes of Health (U.S.); Retrospective Studies; United States; Virus Replication | 2001 |
6 other study(ies) available for kynostatin 272 and zidovudine
| Article | Year |
|---|---|
A new class of anti-HIV agents: synthesis and activity of conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor.
Topics: Anti-HIV Agents; Drug Combinations; HIV Protease Inhibitors; Models, Chemical; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
Topics: Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Gene Products, gag; HIV; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Oligopeptides; Phenylbutyrates; Protein Precursors; Protein Processing, Post-Translational; Radioimmunoprecipitation Assay; Zidovudine | 1993 |
In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI.
Topics: Antiviral Agents; Cells, Cultured; Didanosine; Drug Interactions; HIV Protease Inhibitors; HIV-1; Humans; Leukocytes, Mononuclear; Molecular Structure; Oligopeptides; Phytohemagglutinins; Zidovudine | 1995 |
HIV-1 acquires resistance to two classes of antiviral drugs through homologous recombination.
Topics: Animals; Anti-HIV Agents; Cell Line, Transformed; COS Cells; Didanosine; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Mutagenesis; Oligopeptides; Polymerase Chain Reaction; Recombination, Genetic; Reverse Transcriptase Inhibitors; Transfection; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; HIV Core Protein p24; HIV Protease Inhibitors; HIV-1; Humans; Macrophages; Monocytes; Oligopeptides; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 1998 |
Protease inhibitors: where are they now?
Topics: Animals; Blood Proteins; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Industry; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Oligopeptides; Protein Binding; Pyrones; Quinolines; Rats; Saquinavir; Technology, Pharmaceutical; Urea; Warfarin; Zidovudine | 1995 |